Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Fatima Cody Stanford

Middle-aged adults taking GLP-1s for obesity can save $192K+ on lifetime medical costs, more if they don’t have college degrees, new study finds

The National Bureau of Economic Research paper's lead author hopes putting a dollar value on the benefits of GLP-1s will lead to better access

Fortune

How Obesity Drugs Like Ozempic Could Revolutionize Retirement

GLP-1 drugs like Ozempic and Wegovy are already changing the way we age and manage chronic conditions.

Kiplinger

What happens when Ozempic and Wegovy don’t work?

Patients are shocked when they start getting the weekly injections but hardly lose weight

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Oprah Winfrey opens up about recent weight loss

Media mogul, 69, previously considered using Ozempic for weight loss as taking the ‘easy way out’

The Independent UK

Oprah Winfrey opens up about recent weight loss after admitting she considered Ozempic

Media mogul, 69, previously considered using Ozempic for weight loss as taking the ‘easy way out’

The Independent UK

Rare Ozempic side effects emerging

Though side effects from Ozempic are rare, as usage rises some side effects are becoming more apparent

Salon

Oprah Winfrey reflects on how she was treated while shopping when she weighed more than 200 pounds

‘This is a world that has shamed people for being overweight forever,’ Winfrey says

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Oprah Winfrey admits she refused to take Ozempic and Wegovy for weight loss: ‘That’s the easy way out’

‘I’ve got to do this on my own,’ billionaire media mogul said

The Independent UK

Oprah Winfrey says she refused to take ‘easy way out’ of weight loss drugs Ozempic and Wegovy

‘I’ve got to do this on my own,’ billionaire media mogul said

The Independent UK

Ozempic and Wegovy maker courts prominent Black leaders to get Medicare's favor

Drugmaker Novo Nordisk focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease — worth treating at a cost of $1,000 or more a month.

WEKU

Lifesaving or stigmatizing? Parents wrestle with obesity treatment options for kids

New weight-loss medications and bariatric surgery have the potential to spare children health and social problems. But some parents think they're sending kids the wrong message about their bodies.

WEKU

13 years after bariatric surgery, a 27-year-old says it changed her life

Maria Caprigno was one of the youngest people in the U.S. to get the surgery. As parents and doctors grapple with the obesity treatment for teens, Caprigno cites the long-term benefits.

WEKU

Ask Mr. Dad: Should we be rethinking weight?

Dear Mr. Dad: As someone who has been overweight for most of my childhood and adult life, I am concerned about my son facing the same struggle. I am someone who has felt shame while at the same time being uncomfortable talking about myself as someone with obesity – which,…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Centers for Disease Control and Prevention

228 stories

Wegovy

73 stories

the American Academy of Pediatrics

63 stories

NBER

42 stories

the Congressional Black Caucus

31 stories

the National Bureau of Economic Research

11 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.